Fundraising FoxShangBay Capital LLC — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Petal is developing an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted diseased tissue without incisions, heat, or trauma.
BiotechDeep TechHealthtechMedical DevicesRedwood City, US
Prash Chopra(Founding CEO & Director)Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Prashant Chopra(Executive Officer, Director, Promoter)
BoardFrederic Moll(Director)inRony Abovitz(Co-founding Advisor)
Co-investorsTSVCDolma VenturesK50 VenturesSonder Capital
Petal offers credit card products aimed at helping people access credit, including those new to credit or with past credit issues, by using their savings and spending data to assess creditworthiness beyond a traditional credit score.
ConsumerFintechOxford, US
David Michael Melnick Taffet(Executive Officer)Andrew Endicott(Founder)David Ehrich(Founder)Jack Arenas(Founder)Jason Gross(Founder)in
Co-investorsAfore CapitalBare VenturesEvolution VC PartnersFairhaven Capital PartnersGaingelsGreat Oaks Venture Capital+15 more
__Twitter.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.